NYSE:HUM Humana (HUM) Stock Price, News & Analysis $262.41 +3.05 (+1.18%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Humana Stock (NYSE:HUM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Humana alerts:Sign Up Key Stats Today's Range$254.50▼$276.1450-Day Range$246.07▼$294.9752-Week Range$213.31▼$406.46Volume3.49 million shsAverage Volume1.76 million shsMarket Capitalization$31.67 billionP/E Ratio26.37Dividend Yield1.35%Price Target$284.90Consensus RatingHold Company OverviewHumana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Read More… Humana Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreHUM MarketRank™: Humana scored higher than 79% of companies evaluated by MarketBeat, and ranked 209th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingHumana has received a consensus rating of Hold. The company's average rating score is 2.26, and is based on 6 buy ratings, 17 hold ratings, and no sell ratings.Amount of Analyst CoverageHumana has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-20.28% Earnings GrowthEarnings for Humana are expected to decrease by -20.28% in the coming year, from $16.47 to $13.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 26.37, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.75.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 26.37, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.44.Price to Earnings Growth RatioHumana has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Humana's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.59% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently decreased by 14.75%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldHumana pays a meaningful dividend of 1.34%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 35.58%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 26.96% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. Sustainability and ESG3.9 / 5Environmental Score-0.75 Percentage of Shares Shorted2.59% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently decreased by 14.75%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News Sentiment1.11 News SentimentHumana has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 45 news articles for Humana this week, compared to 24 articles on an average week.Search InterestOnly 5 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -69% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.37% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. Receive HUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter. Email Address HUM Stock News HeadlinesUnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels (HUM)UnitedHealthcare Group is the best house in a rough neighborhood as its still a very profitable vertically integrated healthcare company, not just an insurer.April 22, 2025 | marketbeat.com2 Healthcare Recession-Resistant Stocks Unaffected by TariffsHealth insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.April 15, 2025 | marketbeat.comNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. April 30, 2025 | Paradigm Press (Ad)Health insurers rally after government lays out better-than-expected Medicare Advantage raiseShares of major health insurers jumped early Tuesday after the federal government announced a better-than-expected, 2026 payment increase for Medicare Advantage plansApril 8, 2025 | marketbeat.comHumana Reports $1.2 Billion Profit As Medicare Costs Fall Within ExpectationsApril 30 at 5:14 PM | forbes.comHumana’s exit of some ‘unprofitable’ Medicare plans helps fuel a big profit beatApril 30 at 5:14 PM | msn.comHumana Earnings Beat Expectations. The Stock Is Surging.April 30 at 5:14 PM | msn.comHumana's lower medical costs ease investor fears after UnitedHealth resultsApril 30 at 5:14 PM | msn.comSee More Headlines HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $253.71 on January 1st, 2025. Since then, HUM shares have increased by 3.4% and is now trading at $262.41. View the best growth stocks for 2025 here. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) posted its quarterly earnings results on Wednesday, April, 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The firm's revenue was up 8.4% on a year-over-year basis. Read the conference call transcript. Does Humana have any subsidiaries? Humana subsidiaries include Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others. Who are Humana's major shareholders? Humana's top institutional shareholders include GAMMA Investing LLC (0.65%), Allspring Global Investments Holdings LLC (0.63%), Bank of New York Mellon Corp (0.59%) and Sumitomo Mitsui Trust Group Inc. (0.27%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Timothy S Huval, Samir Deshpande, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM). Company Calendar Record date for 1/31 Dividend12/31/2024Ex-Dividend for 1/31 Dividend12/31/2024Dividend Payable1/31/2025Record date for 4/25 Dividend3/28/2025Ex-Dividend for 4/25 Dividend3/28/2025Dividend Payable4/25/2025Today4/30/2025Last Earnings4/30/2025Next Earnings (Estimated)4/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:HUM CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,100Year Founded1961Price Target and Rating Average Stock Price Target$284.90 High Stock Price Target$326.00 Low Stock Price Target$250.00 Potential Upside/Downside+8.6%Consensus RatingHold Rating Score (0-4)2.26 Research Coverage23 Analysts Profitability EPS (Most Recent Fiscal Year)$9.95 Trailing P/E Ratio26.37 Forward P/E Ratio15.93 P/E Growth2.05Net Income$1.21 billion Net Margins1.02% Pretax Margin1.46% Return on Equity11.70% Return on Assets3.99% Debt Debt-to-Equity Ratio0.68 Current Ratio1.76 Quick Ratio1.76 Sales & Book Value Annual Sales$117.76 billion Price / Sales0.27 Cash Flow$23.08 per share Price / Cash Flow11.37 Book Value$136.57 per share Price / Book1.92Miscellaneous Outstanding Shares120,693,000Free Float120,026,000Market Cap$31.67 billion OptionableOptionable Beta0.62 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NYSE:HUM) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humana Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.